
GMAB Market Capitalization Overview
Market Cap: $20.89B as of Jan 7, 2026
$20.89B
$1.34B (6.81%)past month
As of Jan 7, 2026, GMAB has a market capitalization of $20.89B. Over the past 30 days, its market cap has increased by 1.37%, while in the last 12 months, it has increased by 10.06%.
Market capitalization represents the total value of Genmab - ADR as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
GMAB Market Cap Formula = Stock Price * Shares Outstanding
The market cap of GMAB helps investors assess the company's size and compare it with competitors for better investment decisions.
Market capitalization represents the total value of Genmab - ADR as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
GMAB Market Cap Formula = Stock Price * Shares Outstanding
The market cap of GMAB helps investors assess the company's size and compare it with competitors for better investment decisions.
GMAB Market Cap & Key Trends
See Genmab - ADR’s latest market capitalization, historical trends, and financial insights with AI-powered fundamental data and custom analysis.
Start investing in GMAB
Order type
Buy in
Order amount
Est. shares
0 shares
GMAB Market Cap History
| Date | Market Cap | Change |
|---|---|---|
| Dec 1, 2025 | $19.34B | +9.41% |
| Nov 3, 2025 | $17.68B | -9.63% |
| Oct 1, 2025 | $19.56B | +22.81% |
| Sep 2, 2025 | $15.93B | +18.87% |
| Aug 1, 2025 | $13.40B | +5.01% |
| Jul 1, 2025 | $12.76B | -4.68% |
| Jun 2, 2025 | $13.39B | +4.02% |
| May 1, 2025 | $12.87B | +8.50% |
| Apr 1, 2025 | $11.86B | -18.73% |
| Mar 3, 2025 | $14.60B | +20.20% |
| Feb 3, 2025 | $12.14B | -9.00% |
| Jan 2, 2025 | $13.35B | -3.83% |
GMAB End of Year Market Cap History
| Date | Market Cap | Change |
|---|---|---|
| 2026 | $20.89B | +10.06% |
| 2025 | $18.98B | +43.11% |
| 2024 | $13.26B | -36.26% |
| 2023 | $20.80B | -24.92% |
| 2022 | $27.71B | +7.03% |
| 2021 | $25.89B | — |
FAQs About Genmab - ADR (GMAB) Market Cap
As of Jan 7, 2026, the market capitalization of GMAB is $20.89B. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.
In the last 30 days, Genmab - ADR’s market capitalization has increased by 6.81%, changing from $19.56B to $20.89B as of Jan 7, 2026.
In the last 3 months, Genmab - ADR’s market capitalization has increased by —, changing from – to – as of –.
In the year 2025, Genmab - ADR’s market capitalization increased from $13.26B in January to $18.98B in December, reflecting a 43.11% change.
In the past five years, GMAB has had a compound annual growth rate (CAGR) of -6.02% in market capitalization. This means its market cap has shrunk at an average rate of -6.02% per year.